Lyle Folsom, DPM
Foot & Ankle Surgery · Carlsbad, NMNPI 1770698334
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $519 of the $607 with a category attached, or 85.5%. 8 manufacturers reported payments, led by Stryker at 30.4% of the total. Reporting peaked in 2022 at $239 and has fallen 95.7% since, to $10 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NM, where the typical reported total is $2,589.
Across 23 payments — averaging $26.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$184
- Organogenesis Inc.$117
- Smith+Nephew$91
- Rikco International, LLC$88
- Boston Scientific$57
- Bioventus LLC$44
- plus $24 from 2 others
What the payments were for
- Food & beverage$51985%
- Education$8815%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $184 |
| Organogenesis Inc. | 6 | $117 |
| Smith+Nephew | 4 | $91 |
| Rikco International, LLC | 2 | $88 |
| Boston Scientific | 1 | $57 |
| Bioventus LLC | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Advanced Oxygen Therapy Inc. | 1 | $10 |
How this compares
$607 in reported general payments places this provider in the 20th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 45 | $1,114 |
| Ciclopirox | 22 | $635 |
| Terbinafine Hcl | 43 | $518 |
| Diclofenac Sodium | 17 | $418 |
| Gabapentin | 36 | $307 |
| Clotrimazole | 11 | $270 |
| Cephalexin | 32 | $235 |
| Doxycycline Monohydrate | 15 | $177 |
| Meloxicam | 36 | $149 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Carlsbad
- Joshua WolfeLas Cruces$55K
- Adam GoughSilver City$44K
- Ruben NunezLas Vegas$31K
- Alexander RamirezLas Vegas$22K
- Harsh AminLas Vegas$18K
- Stephanie GonzalezLas Cruces$15K
- Mark MargiottaAlbuquerque$12K
- Lindsy AllenLas Vegas$10K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.